Vanguard Group Inc Longboard Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LBPH
# of Institutions
106Shares Held
30MCall Options Held
16.3KPut Options Held
56.5K-
Cormorant Asset Management, LP Boston, MA3.35MShares$107 Million4.17% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$93.8 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.22MShares$70.8 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.14MShares$68.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.87MShares$59.6 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $434M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...